Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jul:146:110503.
doi: 10.1016/j.jpsychores.2021.110503. Epub 2021 Apr 27.

A randomized double-blind placebo-controlled trial of intravenous thiamine for prevention of delirium following allogeneic hematopoietic stem cell transplantation

Zev M Nakamura  1 , Allison M Deal  2 , Eliza M Park  3 , Laura J Quillen  4 , Stephanie A Chien  4 , Kate E Stanton  2 , Sean D McCabe  5 , Hillary M Heiling  5 , William A Wood  6 , Thomas C Shea  6 , Donald L Rosenstein  3
Affiliations
Randomized Controlled Trial

A randomized double-blind placebo-controlled trial of intravenous thiamine for prevention of delirium following allogeneic hematopoietic stem cell transplantation

Zev M Nakamura et al. J Psychosom Res. 2021 Jul.

Abstract

Objective: To determine if high dose intravenous (IV) thiamine can prevent delirium during hospitalization following allogeneic HSCT. Secondarily, we evaluated the effects of high dose IV thiamine on thiamine levels and explored risk factors for delirium.

Methods: Randomized, double-blind, placebo-controlled trial in patients undergoing allogeneic HSCT at a U.S. academic medical center between October 2017 and March 2020. 64 participants were randomized 1:1 to thiamine 200 mg IV three times daily for 7 days or placebo. We used the Delirium Rating Scale to assess for delirium. Delirium incidence was compared between groups using the chi-square test. Group differences in time to onset and duration of delirium were compared using the Kaplan-Meier method. Fisher's Exact and Wilcoxon Rank Sum tests were used to examine associations between pre-transplantation variables and delirium.

Results: 61 participants were analyzed. Delirium incidence (25% vs. 21%, Chi-square (df = 1) = 0.12, p = 0.73), time to onset, duration, and severity were not different between study arms. Immediately following the intervention, thiamine levels were higher in the thiamine arm (275 vs. 73 nmol/L, t-test (df = 57) = 13.63, p < 0.0001), but not predictive of delirium. Variables associated with delirium in our sample included disease severity, corticosteroid exposure, infection, and pre-transplantation markers of nutrition.

Conclusion: High dose IV thiamine did not prevent delirium in patients receiving allogeneic HSCT. Given the multiple contributors to delirium in this population, further research regarding the efficacy of multicomponent interventions may be needed.

Trial registration: Clinical Trials NCT03263442.

Funding: Rising Tide Foundation for Clinical Cancer Research.

Keywords: Cognitive impairment; Delirium; Hematopoietic stem cell transplantation; Thiamine; Wernicke's encephalopathy; Wernicke-Korsakoff syndrome.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: Dr. Wood receives funding from Pfizer for research not directly related to this work but that could be perceived to constitute a conflict of interest. Otherwise, the authors have no competing interests to report.

Figures

Figure 1.
Figure 1.
Study Schema a. Cognition (Montreal Cognitive Assessment, MoCA), Functional Status (Eastern Cooperative Oncology Group Performance Status, ECOG-PS), Depression (Patient Reported Outcome Measurement Information System, PROMIS), Health-related Quality of Life (Functional Assessment of Cancer Therapy – Bone Marrow Transplant, FACT-BMT) b. Thiamine 200 mg IV three times daily vs. Placebo; post-transplantation days 1-7 c. Delirium Rating Scale (DRS) d. Thiamine levels on post-transplantation days 1, 8, 15, 22, 29
Figure 2.
Figure 2.
Consort Diagram
Figure 3.
Figure 3.
Cumulative incidence of delirium
Figure 4.
Figure 4.
Thiamine levels during hospitalization for allogeneic hematopoietic stem cell transplantation
Figure 5.
Figure 5.
Thiamine deficiency during hospitalization for allogeneic hematopoietic stem cell transplantation
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Siddiqi N, House AO, Holmes JD, Occurrence and outcome of delirium in medical in-patients: a systematic literature review, Age Ageing. 35 (2006) 350–364. https://doi.org/afl005 [pii]. - PubMed
    1. Leslie DL, Inouye SK, The importance of delirium: economic and societal costs, J. Am. Geriatr. Soc 59(2011) S241–S243. 10.1111/j.1532-5415.2011.03671.x. - DOI - PMC - PubMed
    1. Davydow DS, Symptoms of depression and anxiety after delirium, Psychosomatics. 50 (2009) 309–316. 10.1176/appi.psy.50.4.309. - DOI - PubMed
    1. Drews T, Franck M, Radtke FM, Weiss B, Krampe H, Brockhaus WR, Winterer G, Spies CD, Postoperative delirium is an independent risk factor for posttraumatic stress disorder in the elderly patient: a prospective observational study, Eur. J. Anaesthesiol 32 (2015) 147–151. 10.1097/EJA.0000000000000107 [doi]. - DOI - PubMed
    1. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS, Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit, Jama. 291 (2004) 1753–1762. 10.1001/jama.291.14.1753 [doi]. - DOI - PubMed

Publication types

Associated data